EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunosuppression Efficacy via Nonlinear Modeling and Probabilistic Analysis of Human Leukocyte Antigen Match and Dose Effects on Allograft Rejection Risk

Samrajya Raj Acharya iD, Aayush Man Regmi, Sushil Ghimire, Ram Prasad Ghimire

Immunity, Inflammation and Disease · 2025

DOI: 10.1002/iid3.70302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Samrajya Raj Acharya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, School of Science, Kathmandu University, Dhulikhel, Nepal. Hauptthemen laut MEDLINE: Graft Rejection, HLA Antigens, Kidney Transplantation, Immunosuppressive Agents. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human Leukocyte Antigen (HLA) compatibility is a key driver of kidney allograft outcomes, yet how matching interacts with immunosuppressant dosing remains unclear. This study evaluates whether low‐resolution HLA match fractions affect mean dosing and quantified the joint impact of match quality and dose on rejection risk.

Methods

In 519 transplants grouped by HLA match (0–1.0 in 7 strata), full data completeness and variance homogeneity is confirmed, followed by the usage of one‐way ANOVA to compare mean doses. Ridge‐penalized logistic regression models was fitted at each match level to predict rejection probability across low‐ and high‐dose regimens, deriving absolute and relative risk reductions.

Results

ANOVA showed no significant dosing differences by match ( F 6,512 = 0.93, p = 0.47). Logistic models revealed that Absolute Risk Reduction rose from ~0.75% at zero match to ~1.25% at perfect match, while mid‐range match groups (0.2–0.6) yielded the highest total prevented rejections under high‐dose therapy.

Conclusion

Uniform baseline dosing eliminates bias, allowing clear attribution of benefit to immunologic compatibility. These findings endorse a risk‐tailored immunosuppression approach intensifying doses where match is low and potentially reducing them in highly compatible transplants and identify match ranges that maximize rejection prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionHLA AntigensKidney TransplantationImmunosuppressive AgentsImmunosuppression TherapyHumansHistocompatibility TestingMaleFemaleAllograftsTransplantation, HomologousMiddle AgedAdultModels, StatisticalNonlinear Dynamics

Substanzen

HLA AntigensImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Mathematics, School of Science, Kathmandu University, Dhulikhel, Nepal.
  • Department of Mathematics, VIT University, Vellore, India.

ORCID-Profile: Samrajya Raj Acharya

Zitieren

APA

Acharya, S. R., Regmi, A. M., Ghimire, S., & Ghimire, R. P. (2025). Immunosuppression Efficacy via Nonlinear Modeling and Probabilistic Analysis of Human Leukocyte Antigen Match and Dose Effects on Allograft Rejection Risk. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70302

Vancouver

Acharya SR, Regmi AM, Ghimire S, Ghimire RP. Immunosuppression Efficacy via Nonlinear Modeling and Probabilistic Analysis of Human Leukocyte Antigen Match and Dose Effects on Allograft Rejection Risk. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70302

BibTeX
@article{Acharya2025,
  author = {Acharya, Samrajya Raj and Regmi, Aayush Man and Ghimire, Sushil and Ghimire, Ram Prasad},
  title = {Immunosuppression Efficacy via Nonlinear Modeling and Probabilistic Analysis of Human Leukocyte Antigen Match and Dose Effects on Allograft Rejection Risk},
  journal = {Immunity, Inflammation and Disease},
  year = {2025},
  doi = {10.1002/iid3.70302}
}
Kostenlos starten →